Condition
Residual Kidney Function
Total Trials
3
Recruiting
2
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
33%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 2 (1)
P 3 (1)
Trial Status
Recruiting2
Not Yet Recruiting1
Clinical Trials (3)
Showing 3 of 3 trials
NCT05715814Phase 3Recruiting
meChANisms and sAfety of SGLT2 Inhibition in peRitoneal dialYsis
NCT06483074Phase 2Recruiting
Empagliflozin on Residual Kidney Function in Incident Peritoneal Dialysis Patients
NCT06119373Not ApplicableNot Yet Recruiting
Incremental PD With Single Icodextrin Exchange
Showing all 3 trials